Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination

被引:10
作者
Kenny, Grace [1 ,2 ]
Negi, Riya [1 ]
O'Reilly, Sophie [1 ]
Garcia-Leon, Alejandro [1 ]
Alalwan, Dana [1 ]
Gaillard, Colette Marie [1 ]
Saini, Gurvin [1 ]
Inzitari, Rosana [3 ]
Feeney, Eoin R. [1 ,2 ,7 ]
Yousif, Obada [4 ]
Cotter, Aoife G. [1 ,5 ]
de Barra, Eoghan [6 ]
Sadlier, Corinna [8 ]
Crispie, Fiona [9 ,10 ]
Doran, Peter [3 ]
Gautier, Virginie [1 ]
Mallon, Patrick W. G. [1 ,2 ]
机构
[1] Univ Coll Dublin, Ctr Expt Pathogen Host Res CEPHR, Dublin 4, Ireland
[2] St Vincents Univ Hosp, Dept Infect Dis, Elm Pk, Dublin 4, Ireland
[3] Univ Coll Dublin, Sch Med, Dublin 4, Ireland
[4] Wexford Gen Hosp, Endocrinol Dept, Wexford, Ireland
[5] Mater Misericordiae Univ Hosp, Dept Infect Dis, Eccles St, Dublin 7, Ireland
[6] Beaumont Hosp, Dept Infect Dis, Dublin 9, Ireland
[7] Royal Coll Surgeons Ireland, Dept Int Hlth & Trop Med, Dublin, Ireland
[8] Cork Univ Hosp, Dept Infect Dis, Cork, Cork, Ireland
[9] Teagasc Food Res Ctr, Moorepk, Ireland
[10] APC Microbiome Ireland, Cork, Ireland
基金
爱尔兰科学基金会;
关键词
SARS-CoV-2; COVID-19; Serology; ANTIBODIES;
D O I
10.1016/j.jim.2022.113345
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Measurement of quantitative antibody responses are increasingly important in evaluating the immune response to infection and vaccination. In this study we describe the validation of a quantitative, multiplex serologic assay utilising an electrochemiluminescence platform, which measures IgG against the receptor binding domain (RBD), spike S1 and S2 subunits and nucleocapsid antigens of SARS-CoV-2. The assay displayed a sensitivity ranging from 73 to 91% and specificity from 90 to 96% in detecting previous infection with SARS-CoV-2 depending on antigenic target and time since infection, and this assay highly correlated with commercially available assays. The within-plate coefficient of variation ranged from 3.8-3.9% and the inter-plate coefficient of variation from 11 to 13% for each antigen.
引用
收藏
页数:8
相关论文
共 25 条
[1]  
Cohen KW, 2021, CELL REP MED, V2, DOI [10.1016/j.xcrm.2021.100354, 10.1101/2021.04.19.21255739]
[2]  
European Medicines Agency, 2022, COVID 19 VACC
[3]   Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection [J].
Feng, Shuo ;
Phillips, Daniel J. ;
White, Thomas ;
Sayal, Homesh ;
Aley, Parvinder K. ;
Bibi, Sagida ;
Dold, Christina ;
Fuskova, Michelle ;
Gilbert, Sarah C. ;
Hirsch, Ian ;
Humphries, Holly E. ;
Jepson, Brett ;
Kelly, Elizabeth J. ;
Plested, Emma ;
Shoemaker, Kathryn ;
Thomas, Kelly M. ;
Vekemans, Johan ;
Villafana, Tonya L. ;
Lambe, Teresa ;
Pollard, Andrew J. ;
Voysey, Merryn .
NATURE MEDICINE, 2021, 27 (11) :2032-+
[4]   Estimation of the Youden index and its associated cutoff point [J].
Fluss, R ;
Faraggi, D ;
Reiser, B .
BIOMETRICAL JOURNAL, 2005, 47 (04) :458-472
[5]   COVID-19-neutralizing antibodies predict disease severity and survival [J].
Garcia-Beltran, Wilfredo F. ;
Lam, Evan C. ;
Astudillo, Michael G. ;
Yang, Diane ;
Miller, Tyler E. ;
Feldman, Jared ;
Hauser, Blake M. ;
Caradonna, Timothy M. ;
Clayton, Kiera L. ;
Nitido, Adam D. ;
Murali, Mandakolathur R. ;
Alter, Galit ;
Charles, Richelle C. ;
Dighe, Anand ;
Branda, John A. ;
Lennerz, Jochen K. ;
Lingwood, Daniel ;
Schmidt, Aaron G. ;
Iafrate, A. John ;
Balazs, Alejandro B. .
CELL, 2021, 184 (02) :476-+
[6]  
Israel A, 2022, VACCINES-BASEL, V10, DOI [10.3390/vaccines10010064, 10.1101/2021.08.19.21262111]
[7]   COVID19-clinical presentation and therapeutic considerations [J].
Kenny, Grace ;
Mallon, Patrick W. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 :125-131
[8]   Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection [J].
Khoury, David S. ;
Cromer, Deborah ;
Reynaldi, Arnold ;
Schlub, Timothy E. ;
Wheatley, Adam K. ;
Juno, Jennifer A. ;
Subbarao, Kanta ;
Kent, Stephen J. ;
Triccas, James A. ;
Davenport, Miles P. .
NATURE MEDICINE, 2021, 27 (07) :1205-+
[9]   WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community [J].
Knezevic, Ivana ;
Mattiuzzo, Giada ;
Page, Mark ;
Minor, Philip ;
Griffiths, Elwyn ;
Nuebling, Micha ;
Moorthy, Vasee .
LANCET MICROBE, 2022, 3 (03) :E235-E240
[10]   Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic ( VIVALDI study): prospective cohort study in England [J].
Krutikov, Maria ;
Palmer, Tom ;
Tut, Gokhan ;
Fuller, Christopher ;
Azmi, Borscha ;
Giddings, Rebecca ;
Shrotri, Madhumita ;
Kaur, Nayandeep ;
Sylla, Panagiota ;
Lancaster, Tara ;
Irwin-Singer, Aidan ;
Hayward, Andrew ;
Moss, Paul ;
Copas, Andrew ;
Shallcross, Laura .
LANCET HEALTHY LONGEVITY, 2022, 3 (01) :E13-E21